Five major psychiatric disorders and Alzheimer's disease: A bidirectional mendelian randomization study

Document Type

Journal Article

Publication Title

Journal of Alzheimer's Disease





First Page


Last Page


PubMed ID



IOS Press


Centre for Precision Health / School of Medical and Health Sciences


Beijing Natural Science Foundation (JQ19024) National Natural Science Foundation of China (81970996) National Key R&D Program of China (2017YFC1310102 and 2019YFC0118200) Beijing Municipal Science & Technology Commission (Z191100006619046) Edith Cowan University Higher Degree by Research Scholarship (ECU-HDR ST10469322 and ST10468211) Edith Cowan University - Centre for Precision Health HDR Student Award ECU (2021-02406-GUO)

Grant Number

ECU-HDR ST10469322 ST10468211 2021-02406-GUO


Wei, T., Guo, Z., Wang, Z., Li, C., Zhu, W., Zheng, Y., ... & Tang, Y. (2022). Five Major Psychiatric Disorders and Alzheimer’s Disease: A Bidirectional Mendelian Randomization Study. Journal of Alzheimer's Disease, 87(2), pp. 675-684. https://doi.org/10.3233/JAD-220010


Background: Extensive studies put forward the association between Alzheimer's disease (AD) and psychiatric disorders; however, it remains unclear whether these associations are causal. Objective: We aimed to assess the potential causal relationship between major psychiatric disorders and AD. Methods: A bidirectional two-sample Mendelian randomization (MR) was applied to evaluate potential causality between five psychiatric disorders and AD by selecting the single-nucleotide polymorphisms from the genome-wide association studies as instrumental variables. Inverse-variance weighted (IVW) method was used as the main analyzing approach to estimate possible causal effects, alternative methods including MR-Egger, the MR pleiotropy residual sum and outlier, and leave-one-out analysis method were implemented as sensitivity analyzing approaches to ensure the robustness of results. Results: All forward and reverse MR analyses consistently suggested absent causal relations between psychiatric disorders and AD risk [forward IVW: ORADHD, 1.030, 95% CI, 0.908-1.168, p = 0.674; ORanxiety disorders, 0.904, 95% CI, 0.722-1.131, p = 0.377; ORASD, 0.973, 95% CI, 0.746-1.272, p = 0.846; ORBIP, 1.033, 95% CI, 0.925-1.153, p = 0.564; and ORschizophrenia, 1.039, 95% CI, 0.986-1.095, p = 0.156; reverse IVW: ORADHD, 0.993, 95% CI, 0.954-1.034, p = 0.746; ORanxiety disorders, 1.000, 95% CI, 0.999-1.000, p = 0.898; ORASD, 1.001, 95% CI, 0.962-1.042, p = 0.949; ORBIP, 0.997, 95% CI, 0.966-1.028, p = 0.831; and ORschizophrenia, 1.013, 95% CI, 0.978-1.051, p = 0.466]. Conclusion: There is no significant evidence supporting the causal association between the five major psychiatric disorders and AD.



Access Rights

subscription content